New Study Identifies Factors that Determine Trustworthiness of Online Information About Vaccines
March 18, 2020
According to a study published in the March 10, 2020 issue of Vaccine, people who were prompted to evaluate the trustworthiness of vaccine information from online question-and-answer platforms assigned different weights to several criteria depending on whether they were vaccine-confident or vaccine-hesitant. The study’s authors are Associate Professor Ayelet Baram-Tsabari and Dr. Aviv J. Sharon of the Technion Faculty of Education in Science and Technology, together with Dr. Elad Yom-Tov, a visiting scientist at the Technion Faculty of Industrial Engineering and Management.
The World Health Organization states that vaccine hesitancy – the reluctance or refusal to vaccinate despite the availability of vaccines – is one of the top ten threats to global health. Experts are concerned that online vaccine misinformation may be contributing to vaccine hesitancy. Despite this risk, little research attention has been paid to understanding how individuals seek vaccine information online and evaluate its trustworthiness.
The researchers’ findings show that web surfers tend to consider information that encourages vaccination as more trustworthy than information that discourages vaccination, but this is less true for people who are hesitant about vaccines. On average, vaccine-hesitant people’s trustworthiness ratings are more affected by the length of the text provided, suggesting a preference for detailed explanations. Furthermore, across the board, answers provided by health professionals were viewed as more trustworthy than those supplied by parents, which, in turn, were more likely to be perceived as trustworthy than answers that did not mention the writer’s expertise or parenthood status.
These findings are based on 694 participants from the U.S. who rated 600 answers to vaccine-related questions retrieved from “Yahoo! Answers” (e.g., “As a nurse I can tell you without a doubt there is NO WAY you can get HPV from the shot,” written by a self-described health professional). They then rated the trustworthiness of the person who wrote the answer, as they perceived it, and completed a questionnaire concerning their own vaccine hesitancy. The researchers conducted a statistical analysis of the results to find which characteristics of the answers and the raters best predicted the trustworthiness ratings.
“Vaccine hesitancy is a catchall category for several different styles of decision-making about vaccines. Our study shows some ways in which vaccine hesitancy can be manifested in online behavior,” said the lead author, Dr. Aviv J. Sharon. The study’s findings indicate that, despite the proliferation of anti-vaccine messages online, there is still a great deal of public trust in the knowledge provided by mainstream science and medicine. The findings of the study also suggest that expert outreach in online environments may be an effective intervention to address vaccine hesitancy.
For more than a century, the Technion – Israel Institute of Technology has pioneered in science and technology education and delivered world-changing impact. Proudly a global university, the Technion has long leveraged boundary-crossing collaborations to advance breakthrough research and technologies. Now with a presence in three countries, the Technion will prepare the next generation of global innovators. Technion people, ideas, and inventions make immeasurable contributions to the world, innovating in fields from cancer research and sustainable energy to quantum computing and computer science to do good around the world.
The American Technion Society supports visionary education and world-changing impact through the Technion – Israel Institute of Technology. Based in New York City, we represent thousands of US donors, alumni, and stakeholders who invest in the Technion’s growth and innovation to advance critical research and technologies that serve the State of Israel and the global good. Over more than 75 years, our nationwide supporter network has funded new Technion scholarships, research, labs, and facilities that have helped deliver world-changing contributions and extend Technion education to campuses in three countries.